MedTrace Logo

Success Rate of Three Capping Materials

NCT03833557 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2020-04-06

No results posted yet for this study

Summary

A randomized clinical trial was carried out on 72 second primary molars indicated for pulpotomy divided into three equal groups (n=24) . First group received Nanohydroxyapatite as a pulpotomy agent , second group received Mineral Trioxide Aggregate ( MTA) \& the third received Formocresol pulpotomy. All pulpotomized teeth were finally restored with stainless steel crowns. Subjects were monitored clinically and radiographically at one, three , six \& 12 months.

Conditions

  • Caries

Interventions

PROCEDURE

Nanohydroxyapatite Pulpotomy

Biphasic calcium phosphate 500-1000 Um Straumann BoneCeramic

PROCEDURE

MTA pulpotomy

Angleus grey MTA

PROCEDURE

Formocresol Pulpotomy

Buckley's Fromocresol. diluted full strength foromocresol

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-05
Primary Completion
2019-01-10
Completion
2019-01-14

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03833557 on ClinicalTrials.gov